Home NDC 0004-0365 Pegasys
Product NDC 0004-0365
11-digit product format 000040365
Labeler code 0004
Product ID 0004-0365_dcb3ce3c-0f68-4076-88b3-4ee8d818081b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name peginterferon alfa-2a
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Genentech, Inc.
Application BLA103964
Marketing category BLA
Marketing start 2011-11-01
Marketing end 0000-00-00
Substance PEGINTERFERON ALFA-2A
Active strength 180 ug/.5mL
Pharmacologic classes Interferon alpha [EPC],Interferon-alpha [CS]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Pegasys PEGINTERFERON ALFA-2A pharmaand GmbH d9290e5b-6d40-2318-e053-2995a90a9916 2026-07-07 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA103964
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103964 Pegasys peginterferon alfa-2a 351(a) Rx 2026-06-01